Utilización de diuréticos en la administración de hemoderivados: revisión sistemática

  1. Laura Tormos-Claramunt
  2. José Vte Carmona-Simarro
  3. Juan José Tirado Darder
Zeitschrift:
Investigación y cuidados

ISSN: 1698-4587

Datum der Publikation: 2019

Nummer: 38

Seiten: 25-36

Art: Artikel

DIALNET GOOGLE SCHOLAR lock_openOpen Access editor

Andere Publikationen in: Investigación y cuidados

Zusammenfassung

Introduction: Nowadays, the use of diuretics in the administration of blood products is a common practice under the pretext of preventing or mitigating a possible poor tolerance caused by increased blood volume. Objective and method: This research aims to assess and analyze the scientific evidence regarding the use of diuretics in relation to the administration of blood products. It also aims to highlight the possible competencies of nursing professionals in the management of the infusion of blood products and administration of diuretics. Therefore, a systematic review has been carried out by sear ching and analysing articles indexed in MEDLINE and CINAHL published in the last 10 years, in humans and without language restriction. Results and conclusions: Twenty-two articles meeting the established criteria have been included in the present work. The results have shown a lack of standardisation in the criteria justifying the use of diuretics in the administration of blood components. Circulatory overload associated with blood transfusion is the most important transfusion complication that can justify the use of diuretics. In the management of this therapeutic situation, the figure of nurse plays an essential role in its prevention and treatment. It is recommended to carry out studies with scientific rigor that can determine the benefits of the use of diuretics and the criteria for their administration.

Bibliographische Referenzen

  • 1 El uso clínico de la sangre en Medicina General, Obstetricia, Pediatría y Neonatología, Cirugía y Anestesia, Trauma y Quemaduras. [Internet]. Who.int 2001 [consultado 10 de marzo de 2019]. Disponible en: https://www.who.int/ bloodsafety/clinical_use/en/Manual_S.pdf
  • 2 Mechia A, Cometto M C, Gómez P. Protocolo de cuidados de enfermería en la infusión de hemoderivados a pacientes oncológicos. ALADEFE o revista iberoamericana de educación e investigación en enfermería. 2014;3(4):50-58.
  • 3 Fernández-Fresnedo G, Santiago BS, Rodríguez MA. Diuréticos: clasificación y farmacología clínica. Efectos secundarios. Indicaciones prácticas para su empleo clínico. Medicine-Programa de Formación Médica Continuada Acreditado 2003;8(112):5998-6008.
  • 4 Barbolla L, Contreras E, Pujol MM. Manual práctico de medicina transfusional. 2002. 1ª ed. Madrid. Acción Médica.
  • 5 Osterman JL, Arora S. Blood product transfusions and reactions. Hematology Oncology Clinics of North America. 2017;31(6):1159–1170.
  • 6 Sica DA, Carter B, Cushman W, Hamm L. Thiazide and loop diuretics. The journal of clinicalhypertension 2011;13(9):639-643.
  • 7 Basu D, Kulkarni R. Overview of bloodcomponents and theirpreparation. IndianJournal of Anaesthesia 2014;58(5):529- 537.
  • 8 Fernández-Fresnedo G, Santiago BS, Rodríguez MA. Diuréticos: clasificación y farmacología clínica. Efectos secundarios. Indicaciones prácticas para su empleo clínico. Medicine-Programa de Formación Médica Continuada Acreditado 2003;8(112):5998-6008.
  • 9 Cruz-Aranda, J. Enrique. Fármacos diuréticos: alteraciones metabólicas y cardiovasculares en el adulto mayor. Medicina Interna de México, 2018;34(4):566-573.
  • 10 Büntter S, Koch A, Pfeilschifter J. Diuretika-Therapie. DMWDeutsche MedizinischeWochenschrift, 2019;144(6):387- 392.
  • 11 Formulario Modelo de la OMS 2004: Sección 16: Diuréticos [Internet]. Apps.who.int 2004 [citado 2 de junio de 2019]. Disponible en: http://apps.who.int/medicinedocs/ es/d/Js5422s/20.html
  • 12 Pérez Machín M, Sueiro Oyarzun ML, Boffill Cárdenas MD, Morón Rodríguez FJ, Marrero Faz E. Validación de un método in vivo para evaluar la actividad diurética. Revista Cubana de Investigaciones Biomédicas. 2011;30(3):332-44.
  • 13 PRISMA. Transparent reporting of systematic Reviews and Meta- analyses.[Internet]. prisma-statement.org 2019[consultado 5 de abril de 2019] Disponible en: http://www. prisma-statement.org/index.htm.
  • 14 Cabello, J.B. por CASPe. Plantilla para ayudarte a entender un Ensayo Clínico. En: CASPe. Guías CASPe de Lectura Crítica de la Literatura Médica. Alicante: CASPe España; 2005. Cuaderno I. p. 5-8.
  • 15 Alsuhaibani AS, Alnajjar WZ, Alhassan SH, Arif YW, Mashiakhi SQ, AlAhmari AS, et al. Importance of diuretics pre-blood transfusion Running title: Diuretic Pre-Blood Transfusion. Indo American Journal of Pharmaceutical Sciences. artículo especial 2018;5(11):13204-8
  • 16 Alam A, Lin Y, Lima A, Hansen M, Callum JL. Theprevention of transfusion-associatedcirculatoryoverload. Transfusion Medicine Reviews. 2013;27(2):105-112.
  • 17 AndrzejewskiJr C, Casey MA, Popovsky MA. Howweview and approachtransfusion-associatedcirculatoryoverload: pathogenesis, diagnosis, management, mitigation, and prevention. Transfusion. 2013;53(12):3037-47.
  • 18 Aubron C, Aries P, Le Niger C, Sparrow RL, Ozier Y. Howclinicians can minimizetransfusion-related adverse events?TransfusionClinique et Biologique. 2018;25(4):257- 61.
  • 19 Balegar VKK, Kluckow M. Furosemideforpacked red celltransfusion in preterminfants: a randomizedcontrolled trial. TheJournal of pediatrics. 2011;159(6):913-8.
  • 20 Bockhold C, Crumpler S. Responding to pulmonary-relatedbloodtransfusionreactions. Nursing 2018. 2015;45(9):36-41.
  • 21 Daurat A, Grenie J, Roger C, Daurat G, Cuvillon P, Muller L, et al. Outcomes and risk factors of transfusion-associated circulatory overload: a case control study. Transfusion. 2019;59(1):191-5.
  • 22 Elser HE. Islasixafter a bloodtransfusionnecessary? Advances in neonatal care. 2012;12(6):369-370.
  • 23 Frazier SK, Higgins J, Bugajski A, Jones AR, Brown MR. Adverse reactions to transfusion of bloodproducts and bestpracticesforprevention. CriticalCareNursingClinics. 2017;29(3):271-90.
  • 24 Fry JL, Arnold DM, Clase CM, Crowther MA, Holbrook AM, Traore AN, et al. Transfusionpremedication to preventacutetransfusionreactions: a retrospectiveobservationalstudy to assesscurrentpractices. Transfusion. 2010;50(8):1722-30.
  • 25 Le Niger C, Tagne NM, Gentric A. Transfusionsanguinechez les personnesâgées: étudedescriptive à propos de 241 patientsau CHRU de Brest. TransfusionClinique et Biologique. 2018;25(1):49-57.
  • 26 Li G, Rachmale S, Kojicic M, Shahjehan K, Malinchoc M, Kor DJ, et al. Incidence and transfusionriskfactorsfortransfusion-associatedcirculatoryoverloadamong medical intensivecareunitpatients. Transfusion. 2011;51(2):338-43.
  • 27 Lieberman L, Maskens C, Cserti-Gazdewich C, Hansen M, Lin Y, Pendergrast J, et al. A retrospectivereview of patientfactors, transfusionpractices, and outcomes in patientswithtransfusion-associatedcirculatoryoverload. Transfusion Medicine Reviews. 2013;27(4):206-212.
  • 28 Lin Y, Cohen R, Armali C, Callum J, Cserti-Gazdewich C, Lieberman L, et al. Transfusion-associatedcirculatoryoverloadprevention: a retrospectiveobservationalstudy of diuretic use. Vox Sanguinis. 2018;113(4):386-392.
  • 29 Ozier Y. Theprevention of transfusion-associatedcirculatoryoverload. TransfusionClinique et Biologique. 2014;21(4- 5):153-157.
  • 30 Pendergrast J, Armali C, Cserti-Gazdewich C, Hansen M, Kiss A, Lieberman L, et al. Can furosemidepreventtransfusion-associatedcirculatoryoverload? Results of a pilot, double-blind, randomizedcontrolled trial. Transfusion. 2019; 59(6):1-10.
  • 31 Piccin A, Cronin M, Brady R, Sweeney J, Marcheselli L, Lawlor E. Transfusion-associatedcirculatoryoverload in Ireland: a review of cases reported to theNationalHaemovigilance Office 2000 to 2010. Transfusion. 2015;55(6):1223-1230.
  • 32 Roubinian NH, Hendrickson JE, Triulzi DJ, Gottschall JL, Michalkiewicz M, Chowdhury D, et al. Contemporaryriskfactors and outcomes of transfusion-associatedcirculatoryoverload. CriticalCare Medicine. 201;46(4):577-585.
  • 33 Sarai M, Tejani AM. Loopdiureticsforpatientsreceivingbloodtransfusions. Cochrane Database of SystematicReviews. 2015;(2):CD010138.
  • 34 Simpson JD, Hopkins A, Amil A, Ross B, Enjeti AK. Transfusion-associatedcirculatoryoverload in ambulatorypatients. Vox sanguinis. 2019;114 (3):216-222.
  • 35 Tseng E, Spradbrow J, Cao X, Callum J, Lin Y. Anorder set and checklistimprovephysiciantransfusionorderingpractices to mitigatetherisk of transfusion-associatedcirculatoryoverload. Transfusion Medicine. 2016;26(2):104-110.
  • 36 Valieva OA, Strandjord TP, Mayock DE, Juul SE. Effects of transfusions in extremelylowbirthweightinfants: a retrospectivestudy. TheJournal of Pediatrics. 2009;155(3):331-337.
  • 37 Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer’s handbook [internet]. Edinburgo: SIGN; 2008 [consultado 11 de abril de 2019]. Disponible en: http://www.sign.ac.uk/guidelines/fulltext/50/ index. html.
  • 38 Silvergleid AJ, Kleinman S, Tirnauer JS. Transfusion-associatedcirculatoryoverload (TACO) [internet]. uptodate.com 2018 [consultado 11 de abril de 2019]. Disponible en: https:// www.uptodate.com/contents/transfusion-associated-circulatory-overload-taco/print
  • 39 Poles D, Addison J, Carter-Graham S, Fogg A, Mistry H et al. AnnualShotReport 2017 workingwithSeriousHazards of Transfusion [Internet]. Shotuk.org 2018 [consultado 1 de Mayo de 2019]. Disponible en: https://www.shotuk.org/ wp-content/uploads/myimages/SHOT-Report-2017-WEBFinal-v4-25-9-18.pdf
  • 40 FatalitiesReported to FDA FollowingBloodCollection and Transfusion [Internet]. Fda.gov 2017 [consultado 1 de Mayo de 2019]. Disponible en: https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/
  • 41 Guía blanca - Sociedad Española de Transfusión Sanguínea. Guía de transfusión para enfermería. 1ª ed.Madrid: SETS; 2015.
  • 42 Oh SW, Han SY. Loopdiuretics in clinicalpractice. Electrolytes&BloodPressure. 13(1):17-21
  • 43 Fastag E, Varon J, Sternbach G. Richard Lower: theorigins of bloodtransfusion. TheJournal of emergency medicine. 2013;44(6):1146-50.
  • 44 Disponibilidad y seguridad de la sangre a nivel mundial [Internet]. Who.int 2019 [consultado 20 de febrero de 2019]. Disponible en: https://www.who.int/es/news-room/factsheets/detail/blood-safety-and-availability
  • 45 Valderrama Sanabria ML, Estupinán M, Nubia F, Franco Vargas KY. Nursingcare in theadministration of bloodproducts. Revista Cuidarte 2015;6(1):955-963.
  • 46 Aubron C, Aries P, Le Niger C, Sparrow RL, Ozier Y. Howclinicians can minimizetransfusion-related adverse events?TransfusionClinique et Biologique. 2018;25(4):257- 61.
  • 47 Shah A, Stanworth S J, McKechnie S. Evidence and triggersforthetransfusion of blood and bloodproductsAnaesthesia 2015;70(1):10–19.
  • 48 Piccin A, Cronin M, Brady R, Sweeney J, Marcheselli L, Lawlor E. Transfusion-associatedcirculatoryoverload in Ireland: a review of cases reported to theNationalHaemovigilance Office 2000 to 2010. Transfusion. 2015;55(6):1223-1230.
  • 49 Green L, Bolton-Maggs P, Beattie C, Cardigan R, Kallis Y, Stanworth SJ, et al. British Society of HaematologyGuidelinesonthespectrum of freshfrozen plasma and cryoprecipitateproducts: theirhandling and use in variouspatientgroups in theabsence of majorbleeding. British JournalHaematology. 2018;181(1):54-67.
  • 50 Basu D, Kulkarni R. Overview of bloodcomponents and theirpreparation. IndianJournal of Anaesthesia 2014;58(5):529- 537.
  • 51 Bolton Maggs PHB Conferencereport: International HaemovigilanceSeminar and the SHOT AnnualSymposium, 10-12 July 2018. [Internet]. onlinelibrary.wiley.com 2018 [consultado 2 de junio de 2019]. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/tme.12569.
Fuente de los datos: Dialnet